Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

Author： Riemsma Rob  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.1, 2010-08, pp. : 9-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Postmenopausal Metastatic Breast Cancer: A Review of First-Line Treatment Options

By Assersohn L.   Johnston S.R.D.  

American Journal of Cancer, Vol. 2, Iss. 2, 2003-01 ,pp. : 95-109

Adis International

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite

High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study

By                    

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 61-65

Spandidos Publications

Access to resources Recommend Favorite

Aromatase inhibitors in the treatment of early and advanced breast cancer

By Joensuu Heikki   Ejlertsen Bent   Lønning Per   Rutqvist Lars-Erik  

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

First-Line Treatment of Metastatic Breast Cancer: Available Evidence and Current Recommendations

By Puglisi Fabio  

American Journal of Cancer, Vol. 5, Iss. 2, 2006-01 ,pp. : 99-110

Adis International

Access to resources Recommend Favorite